Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion type Assertion NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_head.
- NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion description "[The proteins that were overexpressed are cancer inhibitors (NME, DRG1, IL10), enhancers (SOD2, FAK, IL17, and CREB), and proteins that suppress cancer progression in cells of some cancers and promote it in others (FUT1, integrin beta3, serpin E1, TIAM1, and claudin 4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_provenance.
- NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion evidence source_evidence_literature NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_provenance.
- NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion SIO_000772 21344390 NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_provenance.
- NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion wasDerivedFrom befree-2016 NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_provenance.
- NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_assertion wasGeneratedBy ECO_0000203 NP874436.RAEgkozC_Xrm6Tq6W7T9BbulVfffw8dFmOWOzDYZmfBVs130_provenance.